Last reviewed: June 29, 2026
Last updated: June 29, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide injections work by delivering medication into fatty tissue beneath the skin, where steady absorption supports appetite regulation and metabolic improvements. Choosing the right injection sites and rotating them properly ensures reliable drug delivery and reduces injection-site irritation. This guide covers the anatomy of ideal injection locations and best practices for safe, effective self-administration.
Understanding Subcutaneous Injection Anatomy for Semaglutide
Semaglutide is administered subcutaneously, meaning the needle penetrates skin and enters the adipose tissue layer below. This route of delivery bypasses the digestive system, allowing the medication to be absorbed steadily into the bloodstream over several days. The subcutaneous layer provides a stable depot where semaglutide molecules are released gradually, maintaining consistent therapeutic levels throughout the week.
The depth of subcutaneous tissue varies across the body, with thicker fatty deposits in certain regions ideal for injection. Areas with adequate subcutaneous fat—at least one-quarter inch—ensure the medication lodges in the correct tissue plane rather than muscle or dermis. Understanding this anatomy helps patients identify appropriate injection sites and perform self-injections with confidence.
Ideal Semaglutide Injection Sites on the Body
The abdomen is the most commonly recommended injection site for semaglutide due to its consistent subcutaneous fat layer and ease of self-access. The area two inches around the navel, excluding the navel itself, provides a large surface for site rotation. Injections into abdominal fat are absorbed predictably and cause minimal discomfort for most patients.
The thigh is an excellent alternative injection site, particularly the outer thigh where subcutaneous tissue is abundant. The back of the upper arm, specifically the triceps region, also accommodates semaglutide injections effectively. These secondary sites offer flexibility for patients who prefer variety or wish to reduce repeated injections in a single location.
Buttock tissue provides another viable injection area, though it requires assistance or careful positioning for self-administration. All recommended sites share a common feature: adequate subcutaneous fat depth and minimal nerve or blood vessel density. Patients should avoid areas with scars, bruises, or skin conditions that could compromise injection safety.
Rotation Techniques to Prevent Injection Site Complications
Rotating injection sites is essential for preventing lipodystrophy—localized fat tissue changes that can develop from repeated injections in the same area. A systematic rotation pattern ensures each site receives adequate recovery time between injections. Patients using weekly semaglutide can select a different site each week, creating a four-week rotation cycle across abdomen, thighs, and arms.
Within each anatomical region, spacing injections at least one inch apart prevents tissue trauma and allows healing. Marking injection sites mentally or with a pen helps patients track rotation and avoid overlapping areas. Proper rotation maintains consistent absorption rates and reduces the risk of nodules, induration, or skin dimpling associated with repeated trauma to the same tissue.
Step-by-Step Semaglutide Injection Administration Guide
Before injecting, patients should gather supplies: the semaglutide pen, alcohol swab, gauze, and a sharps container for needle disposal. Wash hands thoroughly and allow the injection site to air-dry after cleaning with an alcohol swab. Inspect the medication for cloudiness or particles—semaglutide should appear clear and colorless.
Gently pinch the skin and fatty tissue at the chosen site to create a raised fold. Insert the needle at a 90-degree angle into the fatty layer, then slowly depress the injection button to deliver medication. Withdraw the needle after the appropriate hold time, release the pinched skin, and apply gentle pressure with gauze if needed. No special massage or rubbing is necessary after injection; simply apply a bandage if desired.
Proper needle depth and technique ensure semaglutide reaches subcutaneous tissue rather than muscle, which could alter absorption and increase discomfort. Patients should never reuse needles and must dispose of all sharps according to local regulations. Consistent technique and site rotation optimize the medication's effectiveness and minimize complications.
When to Seek Help: Injection Site Reactions and Safety Concerns
Mild redness, swelling, or bruising at the injection site typically resolves within hours to days and does not require medical intervention. However, persistent lumps, severe pain, signs of infection (warmth, pus, fever), or allergic reactions warrant immediate medical attention. Patients should contact their healthcare provider if injection-site reactions interfere with continued treatment.
Lipohypertrophy—abnormal thickening of fat tissue—and lipoatrophy—loss of fat tissue—can develop if rotation protocols are not followed consistently. These changes may affect medication absorption and should be reported to the prescribing physician. PlexusDx recommends patients review injection technique at each refill to reinforce proper site selection and rotation practices.
PlexusDx Semaglutide Injections: Personalized Treatment Support
PlexusDx delivers compounded semaglutide injections from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality and safety standards. Patients receive detailed injection instructions with every shipment and can access support resources to master self-administration. PlexusDx semaglutide injections start at $149 per month across all commitment tiers, with pricing that remains flat regardless of dose adjustments.
The Precision Peptide Genetic Test available through PlexusDx analyzes genetic variants in GLP1R (rs6923761), GIPR (rs1800437), and other peptide-pathway genes to identify individual treatment response patterns. This personalized approach helps optimize medication selection and dosing strategy for each patient. PlexusDx serves all 50 states without requiring insurance or membership, making precision weight management accessible to more individuals.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I inject semaglutide into the same spot every week?
No—injecting the same site repeatedly increases the risk of tissue damage, lumps, and absorption inconsistencies. Rotate injection sites systematically across your abdomen, thighs, and arms, spacing sites at least one inch apart. Proper rotation maintains medication effectiveness and prevents lipodystrophy complications.
What is the correct needle angle for semaglutide injection?
Insert the needle at a 90-degree angle (straight in) into the pinched subcutaneous fold to ensure the medication reaches fatty tissue, not muscle or dermis. This angle ensures optimal absorption and reduces discomfort. Maintain steady hand control and depress the injection button slowly for complete medication delivery.
How much does PlexusDx semaglutide injection cost?
PlexusDx compounded semaglutide injections start at $149 per month across all commitment tiers. Your dose may need to go up as treatment progresses, but your price won't. The service is available in all 50 states without insurance requirements, and injections are HSA/FSA eligible.
What should I do if I develop a painful lump at my injection site?
Painful lumps may indicate lipohypertrophy or localized tissue reaction. Stop injecting into that area immediately and contact your healthcare provider for evaluation. Ensure you're rotating sites properly and maintaining appropriate spacing between injections. If symptoms persist or worsen, seek medical attention to rule out infection.
How does the PlexusDx Precision Peptide Genetic Test help with injection therapy?
The Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes to reveal your individual response potential to semaglutide therapy. This genetic insight helps optimize your treatment strategy and injection protocol. The test costs $99 as an add-on after your first month of treatment with PlexusDx.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Your Nutrition: How to Eat While on Wegovy for Lasting Success
What Happens If You Accidentally Inject Ozempic Into a Muscle?